Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

ASC30

A Study to Evaluate the Efficacy, Safety, and Tolerability in Participants With Obesity or Overweight With Weight-Related Comorbidities

Ascletis Pharma (China) Co · Phase 2 · Completed · Enrollment 125

NCT07002905

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

No selected arm reports a responder percent.

Show as table
Arm≥5%≥10%≥15%≥20%
Cohort 1n/rn/rn/rn/r
Cohort 2n/rn/rn/rn/r
Cohort 3n/rn/rn/rn/r
Cohort 4n/rn/rn/rn/r
Cohort 5n/rn/rn/rn/r
Cohort 6n/rn/rn/rn/r
Cohort 7n/rn/rn/rn/r

Not shown

  • Cohort 1: endpoint not reported
  • Cohort 2: endpoint not reported
  • Cohort 3: endpoint not reported
  • Cohort 4: endpoint not reported
  • Cohort 5: endpoint not reported
  • Cohort 6: endpoint not reported
  • Cohort 7: endpoint not reported